Bridgeway Capital Management’s CONTINENTAL RESOURCES INC. CLR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-187,700
Closed -$12.5M 1494
2022
Q3
$12.5M Sell
187,700
-63,400
-25% -$4.28M 0.34% 42
2022
Q2
$16.4M Sell
251,100
-118,100
-32% -$7.49M 0.38% 34
2022
Q1
$22.6M Sell
369,200
-47,450
-11% -$2.63M 0.44% 18
2021
Q4
$18.6M Buy
+416,650
New +$19.8M 0.35% 43
2019
Q3
Sell
-53,800
Closed -$2.26M 1388
2019
Q2
$2.26M Buy
53,800
+46,800
+669% +$2M 0.03% 477
2019
Q1
$313K Sell
7,000
-550,400
-99% -$24.6M ﹤0.01% 1142
2018
Q4
$22.4M Sell
557,400
-96,800
-15% -$4.95M 0.3% 98
2018
Q3
$44.7M Buy
+654,200
New +$41.3M 0.43% 85
2017
Q2
Sell
-1,244,030
Closed -$56.5M 1488
2017
Q1
$56.5M Buy
1,244,030
+164,830
+15% +$7.76M 0.68% 39
2016
Q4
$55.6M Buy
1,079,200
+224,000
+26% +$11.6M 0.73% 21
2016
Q3
$44.4M Buy
855,200
+223,300
+35% +$10.4M 0.66% 27
2016
Q2
$28.6M Buy
+631,900
New +$24.8M 0.44% 73

Other funds holding CLR

Bridgeway Capital Management's CLR Position: Q4 2022 in Review

Bridgeway Capital Management sold out of CONTINENTAL RESOURCES INC. (CLR) in Q4 2022, closing a stake of 187,700 shares — an estimated $12.5M sold.

Bridgeway Capital Management first reported a position in CLR in Q2 2016 and held it in 12 quarters. The position peaked at $56.5M in Q1 2017. 4 funds tracked by Wall St. Rank hold CLR as of Q4 2022.

  • Bridgeway Capital Management reported no remaining CONTINENTAL RESOURCES INC. position as of Q4 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 187,700 CONTINENTAL RESOURCES INC. shares in Q4 2022, an estimated $12.5M.
  • Bridgeway Capital Management first reported a position in CONTINENTAL RESOURCES INC. in Q2 2016 and held it in 12 quarters.
  • Bridgeway Capital Management's CONTINENTAL RESOURCES INC. position peaked at $56.5M in Q1 2017.
  • 4 funds tracked by Wall St. Rank held CONTINENTAL RESOURCES INC. as of Q4 2022.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.